Table 3 Clinical trajectory and context of referral to palliative care
TOTAL | UH 1 | CCC 1 | UH 2 | CCC 2 | UH 3 | |
|---|---|---|---|---|---|---|
Study centre is referent for the patient’s cancer, n/total (%) | 842/932 (90) | 181/200 (91) | 196/200 (98) | 163/199 (82) | 187/200 (94) | 115/133 (87) |
Anteriority of follow up in the centre, Median time in months (Q1 - Q3) | 12 (4–37) | 10 (4–24) | 33 (9–106) | 8 (3–21) | 17 (6–43) | 8 (2–21) |
Intervention by the Palliative Care Team, n/total (%) | 492/926 (53) | 101/196 (52) | 140/199 (70) | 59/196 (30) | 112/199 (56) | 81/136 (60) |
ECOG PS at 1st intervention ≤2 | 95/349 (27) | 23/67 (34) | 43/83 (52) | 5/21 (24) | 12/101 (12) | 12/77 (16) |
Time between first intervention and date of death | n = 475 | n = 98 | n = 138 | n = 55 | n = 107 | n = 77 |
≤ 7 days | 81 (17) | 12 (12) | 10 (2, 7) | 10 (18) | 32 (30) | 17 (22) |
]7–30] days | 117 (25) | 15 (15) | 19 (14) | 22 (40) | 35 (33) | 26 (34) |
]30–90] days | 128 (27) | 39 (40) | 31 (23) | 14 (26) | 24 (22) | 20 (26) |
> 90 days | 149 (31) | 32 (33) | 78 (57) | 9 (16) | 16 (15) | 14 (18) |
median (Q1 - Q3) | 41 (13–122) | 63 (25–115) | 112 (38–281) | 25 (11–50) | 17 (7–54) | 21 (8–64) |